Literature DB >> 34291591

Pure laparoscopic versus robotic liver resections: Multicentric propensity score-based analysis with stratification according to difficulty scores.

Federica Cipriani1, Guido Fiorentini1,2, Paolo Magistri3, Andrea Fontani4, Francesca Menonna5, Mario Annecchiarico6, Andrea Lauterio7, Luciano De Carlis7,8, Andrea Coratti6, Ugo Boggi5, Graziano Ceccarelli4,9, Fabrizio Di Benedetto3, Luca Aldrighetti1,10.   

Abstract

BACKGROUND: The benefits of pure laparoscopic and robot-assisted liver resections (LLR and RALR) are known in comparison to open surgery. The aim of the present retrospective comparative study is to investigate the role of RALR and LLR according to different levels of difficulty.
METHODS: The institutional databases of six high-volume hepatobiliary centers were retrospectively reviewed. The study population was divided in two groups: LLR and RALR. The procedures were stratified for difficulty levels accordingly to three classifications. A propensity score matching was implemented to mitigate selection bias. Short-term outcomes were the object of comparison.
RESULTS: Nine hundred and thirty-six LLR and 403 RALR were collected. RALR exhibited fewer cases of intraoperative blood loss, lower transfusion and conversion rates (especially for oncological radicality) than LLR in the setting of highly difficult operations, whereas LLR had lower postoperative morbidity and fewer low-grade complications. For intermediate and low-difficulty resections, the intraoperative advantages of RALR gradually decreased to nonsignificant results and LLR remained associated with lower postoperative morbidity.
CONCLUSION: Robot-assisted liver resections do not show operative nor clinically significant benefits over LLR for low- and intermediate-difficulty resections. By reducing conversion rates, RALR can favour the operative feasibility of difficult resections possibly extending the indications of minimally invasive approaches for liver resection.
© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  conversion to open surgery; hepatectomy; laparoscopy; propensity score; robotic surgical procedures

Mesh:

Year:  2021        PMID: 34291591     DOI: 10.1002/jhbp.1022

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   3.149


  5 in total

1.  Robotic and laparoscopic right anterior sectionectomy and central hepatectomy: multicentre propensity score-matched analysis.

Authors:  Hye Yeon Yang; Gi Hong Choi; Ken-Min Chin; Sung Hoon Choi; Nicholas L Syn; Tan-To Cheung; Adrian K H Chiow; Iswanto Sucandy; Marco V Marino; Mikel Prieto; Charing C Chong; Jae Hoon Lee; Mikhail Efanov; T Peter Kingham; Robert P Sutcliffe; Roberto I Troisi; Johann Pratschke; Xiaoying Wang; Mathieu D'Hondt; Chung Ngai Tang; Rong Liu; James O Park; Fernando Rotellar; Olivier Scatton; Atsushi Sugioka; Tran Cong Duy Long; Chung-Yip Chan; David Fuks; Ho-Seong Han; Brian K P Goh
Journal:  Br J Surg       Date:  2022-03-15       Impact factor: 6.939

2.  The Role of ICG in Robot-Assisted Liver Resections.

Authors:  Anne-Sophie Mehdorn; Florian Richter; Katharina Hess; Jan Henrik Beckmann; Jan-Hendrik Egberts; Michael Linecker; Thomas Becker; Felix Braun
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

Review 3.  Laparoscopic and Robot-Assisted Hepatic Surgery: An Historical Review.

Authors:  Atsushi Shimizu; Miwa Ito; Alan Kawarai Lefor
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

4.  Short-term outcomes of robotic liver resection: An initial single-institution experience.

Authors:  Manuel Durán; Javier Briceño; Ana Padial; Ferdinando Massimiliano Anelli; Juan Manuel Sánchez-Hidalgo; María Dolores Ayllón; Rafael Calleja-Lozano; Carmen García-Gaitan
Journal:  World J Hepatol       Date:  2022-01-27

Review 5.  What Is the Current Role and What Are the Prospects of the Robotic Approach in Liver Surgery?

Authors:  Emre Bozkurt; Jasper P Sijberden; Mohammed Abu Hilal
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.